AzTrials
AzTrials

Nutritional DeficiencyHPZMNCT02208635

Absorption of Zinc (Zn) From Zn-biofortified and Zn-fortified Maize in Young Zambian Children Between 24-36 Months

A study testing Biofortified Maize and Fortified Maize in people with Nutritional Deficiency, run by University of Colorado, Denver at 2 sites in 2 countries.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The objective of this study is to compare the quantity of Zn absorbed from an accurately weighed quantity (~100 g) of minimally milled control maize (~15 µg Zn/g maize), from biofortified maize (~30 µg Zn/g) and from the same control maize that has been fortified (total level of ~60 µg Zn/g) when fed to young children… Read more about this study

Who is it for?
Ages 24 to 36 monthsHealthy volunteers can take part
Conditions the study is for
Nutritional Deficiency
What is being tested?
Biofortified Maize and Fortified Maize
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
2 sitesin 2 countries
Study dates
Oct 2012to Dec 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 24 to 36 months
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Children age 24 to 36 months
  • Maize meal accounts for at least 75% energy intake
  • Able to consume 100 g maize flour/day
  • Clinically healthy (stunting is acceptable)
  • Lives in target community

Who cannot join

  • Children with chronic or other known chronic disease
  • If children are receiving zinc-fortified products, these products will need to be withheld for 2 weeks prior to the study

Trial locations and contacts

2 sites in 2 countries.

2 sites in 2 countries

United States1 site
  • University of Colorado Anschutz Medical Campus

    Aurora, Colorado, 80045

Other trials in United States

Zambia1 site
  • University Teaching Hospital

    Lusaka

Other trials in Zambia

About this study

The objective of this study is to compare the quantity of Zn absorbed from an accurately weighed quantity (~100 g) of minimally milled control maize (~15 µg Zn/g maize), from biofortified maize (~30 µg Zn/g) and from the same control maize that has been fortified (total level of ~60 µg Zn/g) when fed to young children age 24-36 months whose major habitual food staple is maize.

Read the detailed description

Participating children were randomized to receive an accurately weighed quantity of ~100g/day of either the control, fortified or biofortified study maize for 1 day.

On day 1, mothers brought their child to the health center before breakfast. All meals were extrinsically labeled with a zinc stable isotope (70Zn). Meals on this day were consumed in the presence of the research staff. The quantities of nshima or porridge prepared and eaten were accurately weighed and duplicate meals were collected for subsequent mineral analyses.

Between lunch and dinner on day 1 at the Health Center, a blood sample was collected for Hb and plasma Zn analyses and, immediately after and through the same needle, a stable isotope of zinc was intravenously administered into a forearm vein over 1-2 minutes. The family then returned home.

Morning spot urine samples were collected twice daily starting on day 5 and continuing through day 8. Once these collections were finished, the study for this child was complete.

Dietary Zn was measured from laboratory assays of the duplicate test meals. Fractional absorption of Zn (FAZ) was measured by dual isotope tracer ratio methods in urine. Absorbed Zn was calculated by multiplying dietary Zn by FAZ.

Being tested
Biofortified Maize, Fortified Maize, Control Maize
Keywords
Zinc Absorption, Biofortification, Maize, Zambia, Stable isotopes of Zn
Medical subject headings
Malnutrition, Callosities

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Biofortified MaizeOther

    Participant in this arm were fed zinc biofortified maize (~30 µg Zn/g).

  • Fortified MaizeOther

    Participants in this arm were fed zinc-oxide fortified maize (total level of ~60 µg Zn/g).

  • Control MaizeOther

    Participants in this arm were fed maize that was not fortified or biofortified (~15 µg Zn/g maize).

Study groups in NCT02208635
Study groupRoleWhat they receive
Biofortified MaizeExperimentalParticipants in this arm were fed zinc biofortified maize (~30 µg Zn/g).
Receives: Other: Biofortified Maize
Fortified MaizeExperimentalParticipants in this arm were fed zinc-oxide fortified maize (total level of ~60 µg Zn/g).
Receives: Other: Fortified Maize
Control MaizeActive comparatorParticipants in this arm were fed maize that was not fortified or biofortified (~15 µg Zn/g maize).
Receives: Other: Control Maize

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Absorption of zinc

    Absorption of zinc will be measured in young children fed a diet of control, Zn-biofortified, or Zn-fortified maize. Fractional absorption of zinc from all meals of the day will be measured by extrinsic labeling with stable isotopes of zinc. Fractional absorption of zinc will be measured by a dual isotope tracer ratio technique. Measurement of total zinc in duplicate diets on test day will allow determination of quantity of this micronutrient absorbed (mg/d).

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Aug 2014 (estimated)
  2. Study startOct 2012
  3. Primary completionJan 2014
  4. Study completionDec 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02208635
Sponsor's protocol ID
14-1126
Acronym
HPZM
Status last verified
Apr 2016
First submitted
1 Aug 2014
Last updated
28 Apr 2016
Results posted
No
Data monitoring committee
No

Publications

  • Chomba E, Westcott CM, Westcott JE, Mpabalwani EM, Krebs NF, Patinkin ZW, Palacios N, Hambidge KM. Zinc absorption from biofortified maize meets the requirements of young rural Zambian children. J Nutr. 2015 Mar;145(3):514-9. doi: 10.3945/jn.114.204933. Epub 2015 Jan 21.

    PubMed 25733467

Questions about this trial

What is this clinical trial studying?

A study testing Biofortified Maize and Fortified Maize in people with Nutritional Deficiency, run by University of Colorado, Denver at 2 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Apr 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States, Zambia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Absorption of zinc (time frame: 1 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02208635, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Apr 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in